HIF1A and cancer: Deletion of p53 in cancer cells increases HIF-1α levels and enhances transcriptional activation of HIF-1α-dependent VEGF and erythropoietin (EPO) in response to hypoxia, thus promoting EC proliferation, migration, and angiogenesis (63, 64).